Press release
Enterobacteriaceae Infection Drug: A Guide to Understanding the Process
Enterobacteriaceae Infection Drug Market
Enterobacteriaceae are a large family of different types of germs (bacteria) that commonly cause infections in healthcare settings. Examples of germs in the Enterobacteriaceae family include Escherichia coli (E. coli) and Klebsiella pneumoniae.
MARKET DYNAMICS
Rising prevalence of Enterobacteriaceae infectious diseases, For instance, in 2021, CRE caused an estimated 13,100 infections in hospitalized patients, and 1,100 estimated deaths in the United States increasing modes of spread of the infectious disease and a lack of cleanliness are the driving factors. However, the major factor which will restrain the market growth rapid resistance to drugs currently available for enterobacter infections. Furthermore, launch of new antibiotics with activity against carbapenem-resistant Enterobacteriaceae (CRE) will offer lucrative opportunities in the market.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00008464?utm_source=OpenPR&utm_medium=10852
Enterobacteriaceae Infection Drug Market: Competitive Landscape and Key Developments:
1. Genentech, Inc.
2. Allergan
3. Novartis AG
4. Pfizer Inc.
5. Nymox Pharmaceutical Corporation
6. Sequoia Sciences, Inc.
7. Phico Therapeutics Ltd.
8. Melinta Therapeutics, Inc.
9. Spero Therapeutics
10. Cipla USA, Inc.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enterobacteriaceae Infection Drug: A Guide to Understanding the Process here
News-ID: 3870165 • Views: …
More Releases from The Insight Partners
Polymer Derived Ceramics Market Outlook 2026-2034: Key Players Include COI Ceram …
The Polymer Derived Ceramics Market revolutionizes high-performance materials by transforming polymers into ceramics that withstand extreme temperatures and harsh environments. Industries from aerospace to electronics embrace these versatile solutions for their lightweight strength, oxidation resistance, and precision engineering capabilities.
Download PDF: -https://www.theinsightpartners.com/sample/TIPRE00014638?utm_source=Openpr&utm_medium=10413
Leading companies like CeramTec, Ube Industries, KYOCERA, COI Ceramics, Hitachi Chemical, Ultramet, and Pyromeral Systems spearhead innovation through advanced sintering and additive manufacturing processes. Recent strides in nanostructuring and eco-friendly…
Feed Grade Mono Calcium Phosphate Market Forecast to 2031 - Trends, Segmentation …
With livestock farming intensifying globally to meet growing demand for meat, dairy, and related animal‐products, feed additives have become central to maintaining animal health, growth, and productivity. One such additive, Feed Grade Mono Calcium Phosphate , is especially important for supplying calcium and phosphorus in feed. According to reports from The Insight Partners, the MCP market is set for robust growth from now through 2031.
Check valuable insights in the…
Medical Injection Molding Powers Precision in Healthcare Device Manufacturing
Medical injection molding transforms raw materials into intricate components essential for syringes, implants, and diagnostic tools, enabling faster production of life-saving devices. Healthcare innovators rely on this technology to meet rising demands for customized, high-quality medical products amid evolving patient needs.
👉 Download the Report Here: https://www.theinsightpartners.com/sample/TIPRE00009102/?utm_source=OpenPR&utm_medium=10129
Key Market Insights by 2031
Medical injection molding excels in creating precise parts for medical devices, from consumables to orthopedic instruments, ensuring biocompatibility and reliability. Service…
Arc Welding Equipment Market Forecast 2031: Key Trends, Growth Drivers & Industr …
December 26, 2025 - The Arc Welding Equipment Market is expected to register a CAGR of 5.9% from 2025 to 2031. The Arc Welding Equipment Market is undergoing a transformative phase as global industries increasingly adopt advanced welding solutions. With the growing need for precision, efficiency, and sustainability, the market is poised for consistent expansion through 2031. Industrial sectors such as automotive, aerospace, construction, and shipbuilding are embracing automated, semi-automatic,…
More Releases for Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Market is expected to re …
Carbapenem-resistant Enterobacteriaceae (CRE) represent one of the most dangerous groups of multidrug-resistant (MDR) bacteria, including Klebsiella pneumoniae and Escherichia coli. These pathogens are resistant to nearly all available antibiotics, including carbapenems, which are considered last-resort treatments.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71765
CRE infections are associated with high mortality rates (up to 50%), prolonged hospital stays, and major economic burden. They occur most often in hospitalized, immunocompromised, and…
Global Carbapenem-Resistant Enterobacteriaceae (CRE) Testing Market to Reach USD …
The global Carbapenem-resistant Enterobacteriaceae (CRE) testing market is experiencing significant growth, driven by the escalating prevalence of CRE infections and the imperative need for rapid, The global carbapenem-resistant enterobacteriaceae testing market is estimated at a value of US$ 4.25 billion in 2024 and is forecasted to reach a size of US$ 8.89 billion by 2034-end. Worldwide demand is projected to advance at a 7.7% CAGR from 2024 to 2034.
Market Development
The…
Enterobacteriaceae Infection Drug Market Trends, Research, Analysis & Forecast 2 …
The latest Enterobacteriaceae Infection Drug Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thoroughanalysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as most wide-ranging documentation that comprises all the aspects of the evolving Enterobacteriaceae Infection…
Enterobacteriaceae Infection Drug Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Enterobacteriaceae Infection Drug Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Enterobacteriaceae Infection Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
Carbapenem-resistant Enterobacteriaceae Testing Market to Partake Significant De …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii. These…
Carbapenem-resistant Enterobacteriaceae Testing Market Analysis, Segments, Growt …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
These gram-negative…
